bioRxivBiochemistry
Structure-guided stabilization improves the ability of the HIV-1 gp41 hydrophobic pocket to elicit neutralizing antibodies
T. U. J. Bruun, S. Tang, G. Erwin, L. Deis, D. Fernandez, P. S. Kim
Abstract
The hydrophobic pocket found in the N-heptad repeat (NHR) region of HIV-1 gp41 is a highly conserved epitope that is the target of various HIV-1 neutralizing monoclonal antibodies. Although the high conservation of the pocket makes it an attractive vaccine candidate, it has been challenging to elicit potent anti-NHR antibodies via immunization. Here, we solved a high-resolution structure of the NHR mimetic IQN17, and, consistent with previous ligand-bound gp41 pocket structures, we observed remarkable conformational plasticity of the pocket. The high malleability of this pocket led us to test whether we could improve the immunogenicity of the gp41 pocket by stabilizing its conformation. We show that the addition of five amino acids at the C-terminus of IQN17, to generate IQN22, introduces a stabilizing salt bridge at the base of the peptide that rigidifies the pocket. Mice immunized with IQN22 elicited higher avidity antibodies against the gp41 pocket and a more potent, albeit still weak, neutralizing response against HIV-1 compared to IQN17. Stabilized epitope-focused immunogens could serve as the basis for future HIV-1 fusion-inhibiting vaccines.
- organism: mouse
- assay: proteomics
- research focus: drug response / drug discovery
- research focus: host-pathogen & immune response
- approach: experimental assay
- approach: wet-lab / biochemical assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HIV-1 vaccine design through minimizing envelope metastability
- Structure of HIV-1 gp41 with its membrane anchors targeted by neutralizing antibodies
C. Caillat, D. Guilligay, … W. Weissenhorn·bioRxiv·Nov 12, 2020
- Designed nanofiber immunogens prime antibody responsesto diverse conformations of the HIV-1 fusion peptide
Chelsea N. Fries, Jui-Lin Chen, … Joel H. Collier·bioRxiv·Oct 5, 2026
- Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
K. Xu, P. Acharya, … McDermott·bioRxiv·Apr 23, 2018
- Broadly Neutralizing Antibody Epitopes on HIV-1 Particles are exposed after Virus Interaction with Host Cells
P. G. Rao, G. S. Lambert, C. Upadhyay·bioRxiv·Jan 20, 2023
- A derivative of the D5 monoclonal antibody that targets the gp41 N-heptad repeat of HIV-1 with broad tier-2 neutralizing activity
A. A. Rubio, M. V. Filsinger Interrante, … P. S. Kim·bioRxiv·Oct 23, 2020